The NATURE” Trial: Nutritional Adjunctive Treatment Used for Recovery in Early psychosis
Not Applicable
Not yet recruiting
- Conditions
- first-episode psychosis
- Registration Number
- ACTRN12618000704291
- Lead Sponsor
- Western Sydney University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the nutritional formula's impact on negative symptoms in first-episode psychosis?
How does the NATURE trial's intervention compare to standard-of-care treatments for negative symptoms in early psychosis?
Are there specific biomarkers that can predict response to the nutritional adjunctive treatment in ACTRN12618000704291?
What are the potential adverse events associated with the novel nutritional formula in first-episode psychosis patients?
What related compounds or combination therapies are being explored as adjunctive treatments for negative symptoms in early psychosis?